|
1
|
Doll R and Peto R: The causes of cancer:
Quantitative estimates of avoidable risks of cancer in the United
States today. J Natl Cancer Inst. 66:1191–1308. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Suzuki K, Suzuki I, Leodolter A, Alonso S,
Horiuchi S, Yamashita K and Perucho M: Global DNA demethylation in
gastrointestinal cancer is age dependent and precedes genomic
damage. Cancer Cell. 9:199–207. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Goll MG and Bestor TH: Eukaryotic cytosine
methyltransferases. Annu Rev Biochem. 74:481–514. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Ito S, Shen L, Dai Q, Wu SC, Collins LB,
Swenberg JA, He C and Zhang Y: Tet proteins can convert
5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine.
Science. 333:1300–1303. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Maiti A and Drohat AC: Thymine DNA
glycosylase can rapidly excise 5-formylcytosine and
5-carboxylcytosine: Potential implications for active demethylation
of CpG sites. J Biol Chem. 286:35334–35338. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tahiliani M, Koh KP, Shen Y, Pastor WA,
Bandukwala H, Brudno Y, Agarwal S, Iyer LM, Liu DR, Aravind L and
Rao A: Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in
mammalian DNA by MLL partner TET1. Science. 324:930–935. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Scourzic L, Mouly E and Bernard OA: TET
proteins and the control of cytosine demethylation in cancer.
Genome Med. 7:92015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Good CR, Panjarian S, Kelly AD, Madzo J,
Patel B, Jelinek J and Issa JJ: TET1-mediated hypomethylation
activates oncogenic signaling in triple-negative breast cancer.
Cancer Res. 78:4126–4137. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hsu CH, Peng KL, Kang ML, Chen YR, Yang
YC, Tsai CH, Chu CS, Jeng YM, Chen YT, Lin FM, et al: TET1
suppresses cancer invasion by activating the tissue inhibitors of
metalloproteinases. Cell Rep. 2:568–579. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yan B, Guo Q, Fu FJ, Wang Z, Yin Z, Wei YB
and Yang JR: The role of miR-29b in cancer: Regulation, function,
and signaling. Onco Targets Ther. 8:539–548. 2015.PubMed/NCBI
|
|
11
|
Zhang Z, Cao Y, Zhai Y, Ma X, An X, Zhang
S and Li Z: MicroRNA-29b regulates DNA methylation by targeting
Dnmt3a/3b and Tet1/2/3 in porcine early embryo development. Dev
Growth Differ. 60:197–204. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chou J, Lin JH, Brenot A, Kim JW, Provot S
and Werb Z: GATA3 suppresses metastasis and modulates the tumour
microenvironment by regulating microRNA-29b expression. Nat Cell
Biol. 15:201–213. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang H, An X, Yu H, Zhang S, Tang B, Zhang
X and Li Z: MiR-29b/TET1/ZEB2 signaling axis regulates metastatic
properties and epithelial-mesenchymal transition in breast cancer
cells. Oncotarget. 8:102119–102133. 2017.PubMed/NCBI
|
|
14
|
Wong EM, Southey MC, Fox SB, Brown MA,
Dowty JG, Jenkins MA, Giles GG, Hopper JL and Dobrovic A:
Constitutional methylation of the BRCA1 promoter is specifically
associated with BRCA1 mutation-associated pathology in early-onset
breast cancer. Cancer Prev Res (Phila). 4:23–33. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Gupta S, Jaworska-Bieniek K, Narod SA,
Lubinski J, Wojdacz TK and Jakubowska A: Methylation of the BRCA1
promoter in peripheral blood DNA is associated with triple-negative
and medullary breast cancer. Breast Cancer Res Treat. 148:615–622.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Iwamoto T, Yamamoto N, Taguchi T, Tamaki Y
and Noguchi S: BRCA1 promoter methylation in peripheral blood cells
is associated with increased risk of breast cancer with BRCA1
promoter methylation. Breast Cancer Res Treat. 129:69–77. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Al-Moghrabi N, Nofel A, Al-Yousef N,
Madkhali S, Bin Amer SM, Alaiya A, Shinwari Z, Al-Tweigeri T,
Karakas B, Tulbah A and Aboussekhra A: The molecular significance
of methylated BRCA1 promoter in white blood cells of cancer-free
females. BMC Cancer. 14:8302014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dobrovic A, Mikeska T, Alsop K, Candiloro
I, George J, Mitchell G and Bowtell D: Constitutional BRCA1
methylation is a major predisposition factor for high-grade serous
ovarian cancer. Cancer Res. 742014.
|
|
19
|
Al-Moghrabi NM: BRCA1 promoter methylation
in peripheral blood cells and predisposition to breast cancer. J
Taibah Univ Med Sci. 12:189–193. 2017.PubMed/NCBI
|
|
20
|
Wei M, Grushko TA, Dignam J, Hagos F,
Nanda R, Sveen L, Xu J, Fackenthal J, Tretiakova M, Das S and
Olopade OI: BRCA1 promoter methylation in sporadic breast cancer is
associated with reduced BRCA1 copy number and chromosome 17
aneusomy. Cancer Res. 65:10692–10699. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Butcher DT, Mancini-DiNardo DN, Archer TK
and Rodenhiser DI: DNA binding sites for putative methylation
boundaries in the unmethylated region of the BRCA1 promoter. Int J
Cancer. 111:669–678. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Xu J, Huo D, Chen Y, Nwachukwu C, Collins
C, Rowell J, Slamon DJ and Olopade OI: CpG island methylation
affects accessibility of the proximal BRCA1 promoter to
transcription factors. Breast Cancer Res Treat. 120:593–601. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji H, Liu YE, Jia T, Wang M, Liu J, Xiao
G, Joseph BK, Rosen C and Shi YE: Identification of a breast
cancer-specific gene, BCSG1, by direct differential cDNA
sequencing. Cancer Res. 57:759–764. 1997.PubMed/NCBI
|
|
24
|
Wu K, Quan Z, Weng Z, Li F, Zhang Y, Yao
X, Chen Y, Budman D, Goldberg ID and Shi YE: Expression of neuronal
protein synuclein gamma gene as a novel marker for breast cancer
prognosis. Breast Cancer Res Treat. 101:259–267. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Lu A, Gupta A, Li C, Ahlborn TE, Ma Y, Shi
EY and Liu J: Molecular mechanisms for aberrant expression of the
human breast cancer specific gene 1 in breast cancer cells: Control
of transcription by DNA methylation and intronic sequences.
Oncogene. 20:5173–5185. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lu A, Zhang F, Gupta A and Liu J: Blockade
of AP1 transactivation abrogates the abnormal expression of breast
cancer-specific gene 1 in breast cancer cells. J Biol Chem.
277:31364–31372. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Song X, Zhang M, Dai E and Luo Y:
Molecular targets of curcumin in breast cancer (Review). Mol Med
Rep. 19:23–29. 2019.PubMed/NCBI
|
|
28
|
Jiang A, Wang X, Shan X, Li Y, Wang P,
Jiang P and Feng Q: Curcumin reactivates silenced tumor suppressor
Gene RARβ by reducing DNA methylation. Phytother Res. 29:1237–1245.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Kumar U, Sharma U and Rathi G: Reversal of
hypermethylation and reactivation of glutathione S-transferase pi 1
gene by curcumin in breast cancer cell line. Tumour Biol.
39:10104283176922582017. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Du L, Xie Z, Wu LC, Chiu M, Lin J, Chan
KK, Liu S and Liu Z: Reactivation of RASSF1A in breast cancer cells
by curcumin. Nutr Cancer. 64:1228–1235. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zheng J, Wu C, Lin Z, Guo Y, Shi L, Dong
P, Lu Z, Gao S, Liao Y, Chen B and Yu F: Curcumin up-regulates
phosphatase and tensin homologue deleted on chromosome 10 through
microRNA-mediated control of DNA methylation-a novel mechanism
suppressing liver fibrosis. FEBS J. 281:88–103. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Link A, Balaguer F, Shen Y, Lozano JJ,
Leung HC, Boland CR and Goel A: Curcumin modulates DNA methylation
in colorectal cancer cells. PLoS One. 8:e577092013. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Birgisdottir V, Stefansson OA,
Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG and Eyfjord JE:
Epigenetic silencing and deletion of the BRCA1 gene in sporadic
breast cancer. Breast Cancer Res. 8:R382006. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu H, Liu W, Wu Y, Zhou Y, Xue R, Luo C,
Wang L, Zhao W, Jiang JD and Liu J: Loss of epigenetic control of
synuclein-gamma gene as a molecular indicator of metastasis in a
wide range of human cancers. Cancer Res. 65:7635–7643. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Al-Moghrabi N, Al-Showimi M, Al-Yousef N,
Al-Shahrani B, Karakas B, Alghofaili L, Almubarak H, Madkhali S and
Al Humaidan H: Methylation of BRCA1 and MGMT genes in white blood
cells are transmitted from mothers to daughters. Clin Epigenetics.
10:992018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Tost J and Gut IG: DNA methylation
analysis by pyrosequencing. Nat Protoc. 2:2265–2275. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hendrayani SF, Al-Khalaf HH and
Aboussekhra A: Curcumin triggers p16-dependent senescence in active
breast cancer-associated fibroblasts and suppresses their paracrine
procarcinogenic effects. Neoplasia. 15:631–640. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Vaughan RA, Garcia-Smith R, Dorsey J,
Griffith JK, Bisoffi M and Trujillo KA: Tumor necrosis factor alpha
induces Warburg-like metabolism and is reversed by
anti-inflammatory curcumin in breast epithelial cells. Int J
Cancer. 133:2504–2510. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gupta A, Godwin AK, Vanderveer L, Lu A and
Liu J: Hypomethylation of the synuclein gamma gene CpG island
promotes its aberrant expression in breast carcinoma and ovarian
carcinoma. Cancer Res. 63:664–673. 2003.PubMed/NCBI
|
|
41
|
Hu S, Xu Y, Meng L, Huang L and Sun H:
Curcumin inhibits proliferation and promotes apoptosis of breast
cancer cells. Exp Ther Med. 16:1266–1272. 2018.PubMed/NCBI
|
|
42
|
Feilotter HE, Michel C, Uy P, Bathurst L
and Davey S: BRCA1 haploinsufficiency leads to altered expression
of genes involved in cellular proliferation and development. PLoS
One. 9:e1000682014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Ma Z, Niu J, Sun E, Rong X, Zhang X and Ju
Y: Gamma-synuclein binds to AKT and promotes cancer cell survival
and proliferation. Tumour Biol. 37:14999–15005. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
He JS, Xie N, Yang JB, Guan H, Chen WC,
Zou C, Ouyang YW, Mao YS, Luo XY, Pan Y and Fu L: BCSG1 siRNA
delivered by lentiviral vector suppressed proliferation and
migration of MDA-MB-231 cells. Int J Mol Med. 41:1659–1664.
2018.PubMed/NCBI
|
|
45
|
Pei YF, Tao R, Li JF, Su LP, Yu BQ, Wu XY,
Yan M, Gu QL, Zhu ZG and Liu BY: TET1 inhibits gastric cancer
growth and metastasis by PTEN demethylation and re-expression.
Oncotarget. 7:31322–31335. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kai M, Niinuma T, Kitajima H, Yamamoto E,
Harada T, Aoki H, Maruyama R, Toyota M, Sasaki Y, Sugai T, et al:
TET1 Depletion induces aberrant CpG methylation in colorectal
cancer cells. PLoS One. 11:e01682812016. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Chen J, Ying Y, Zhu H, Zhu T, Qu C, Jiang
J and Fang B: Curcumin-induced promoter hypermethylation of the
mammalian target of rapamycin gene in multiple myeloma cells. Oncol
Lett. 17:1108–1114. 2019.PubMed/NCBI
|
|
48
|
Liu H, Zhou Y, Boggs SE, Belinsky SA and
Liu J: Cigarette smoke induces demethylation of prometastatic
oncogene synuclein-gamma in lung cancer cells by downregulation of
DNMT3B. Oncogene. 26:5900–5910. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Morita S, Horii T, Kimura M, Ochiya T,
Tajima S and Hatada I: miR-29 represses the activities of DNA
methyltransferases and DNA demethylases. Int J Mol Sci.
14:14647–14658. 2013. View Article : Google Scholar : PubMed/NCBI
|
